Analysts’ new coverage for Wednesday, September 23rd:
Needham & Company LLC started coverage on shares of Belden (NYSE:BDC). Needham & Company LLC issued a buy rating and a $140.00 target price on the stock.
Oppenheimer Holdings, Inc. initiated coverage on shares of Collegium Pharmaceutical (NASDAQ:COLL). They issued an outperform rating and a $50.00 price target on the stock.
Cantor Fitzgerald assumed coverage on shares of Enhanced Group (NYSE:ENHA). They issued an overweight rating and a $4.00 target price on the stock.
Oppenheimer Holdings, Inc. initiated coverage on shares of Innoviva (NASDAQ:INVA). The firm issued an outperform rating and a $35.00 price target on the stock.
New Street Research assumed coverage on shares of MercadoLibre (NASDAQ:MELI). They issued a buy rating and a $2,450.00 price target on the stock.
BTIG Research assumed coverage on shares of Oric Pharmaceuticals (NASDAQ:ORIC). They issued a buy rating and a $26.00 target price on the stock.
Oppenheimer Holdings, Inc. started coverage on shares of Pacira BioSciences (NASDAQ:PCRX). The firm issued an outperform rating and a $32.00 price target on the stock.
Lake Street Capital began coverage on shares of Quoin Pharmaceuticals (NASDAQ:QNRX). The firm issued a buy rating and a $20.00 price target on the stock.
Oppenheimer Holdings, Inc. started coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA). The firm issued an outperform rating and a $50.00 price target on the stock.
Oppenheimer Holdings, Inc. started coverage on shares of Toro (NYSE:TTC). Oppenheimer Holdings, Inc. issued an outperform rating and a $120.00 price target on the stock.
JPMorgan Chase & Co. initiated coverage on shares of WAVE Life Sciences (NASDAQ:WVE). JPMorgan Chase & Co. issued a neutral rating on the stock.
Receive News & Ratings for Belden Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Belden Inc and related companies with MarketBeat.com's FREE daily email newsletter.
